Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study)
ACT-TBI
1 other identifier
interventional
200
1 country
4
Brief Summary
Background: Severe traumatic brain injury (TBI) is a principal cause of post-injury hospitalization, disability, and death throughout the world. TBI is the leading cause of death and disability among young healthy people under 45 years of age and is predicted to be the most prevalent and costliest neurological condition in Canada through the year 2031. TBI is commonly classified into mild, moderate, and severe categories using the Glasgow Coma Scale (GCS), with "severe TBI" defined as a GCS score ≤ 8. Severe TBI is a clinical emergency, during which the trauma team works swiftly to provide the appropriate care. Outcome assessment after TBI is complex and is influenced by pre-injury and injury factors as well as the patient's response at various stages of recovery. The first 48 hrs in hospital, despite being the most resource-intensive period, unfortunately result in the highest mortality. These patients are on life support at the time of their hospital admission and adequate and reliable clinical examination is impossible. Thus, patients receive treatment despite lack of a clear understanding of their prognoses. Hypothesis: Admission Computed Tomographic Perfusion (CTP) can diagnose brain death reliably in severe TBI patients in early stage upon hospital admission, which is not recognised in the usual clinical practice due to inadequate reliable clinical examination. In a small prospective pilot study of 19 patients with severe TBI, admission CTP could predict early in hospital mortality with 75% sensitivity, 100% specificity, 100% positive predictive value (PPV) and 94% negative predictive value (NPV) and perfect inter-rater reliability (kappa=1). We propose ACT-TBI study to evaluate CTP as a triage tool to diagnose early mortality at the time of admission in patients with severe TBI. Primary Objective: To validate admission CTP features of brain death, relative to the clinical examination outcome, for characterizing early in-hospital mortality. Secondary objectives: To establish the safety and interrater reliability of admission CTP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2020
CompletedFirst Posted
Study publicly available on registry
March 24, 2020
CompletedStudy Start
First participant enrolled
July 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2023
CompletedJanuary 19, 2024
January 1, 2024
3 years
March 20, 2020
January 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome is a binary outcome of mortality ('dead') or survival ('not-dead') in the first 48 hours of hospital admission.
The primary outcome of this study is determining the mortality ('dead') or survival ('not-dead') in the first 48 hours of hospital admission using CTP.
48 hours
Secondary Outcomes (1)
In-hospital mortality at the end of hospital discharge.
6 months
Study Arms (1)
CT Perfusion
EXPERIMENTALSevere TBI patients will be undergoing CT perfusion test
Interventions
Severe Traumatic Brain Injury patients will be undergoing CT perfusion test
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Severe head injury with the activation of the trauma code
- GCS score ≤ 8 after initial resuscitation
- On mechanical respiratory ventilation at the time of imaging
You may not qualify if:
- No known GCS after initial resuscitation
- Known pregnancy
- Known contraindication to CT contrast agent, e.g.,allergy or anaphylactic reaction
- Known end-stage renal disease stage 4-5 (eGFR \< 30 mL/min/1.73 m2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Health Sciences Centre
Winnipeg, Manitoba, R3A 1R9, Canada
QEII Health Scienecs Centre
Halifax, Nova Scotia, B3K 4N1, Canada
The Ottawa Hospital
Ottawa, Ontario, K1Y 4E9, Canada
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, H2X 0C1, Canada
Related Publications (1)
Alcock S, Batoo D, Ande SR, Grierson R, Essig M, Martin D, Trivedi A, Sinha N, Leeies M, Zeiler FA, Shankar JJS. Early diagnosis of mortality using admission CT perfusion in severe traumatic brain injury patients (ACT-TBI): protocol for a prospective cohort study. BMJ Open. 2021 Jun 9;11(6):e047305. doi: 10.1136/bmjopen-2020-047305.
PMID: 34108167DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jai Shankar, MD FRCPC
University of Manitoba
- PRINCIPAL INVESTIGATOR
Frederick Zeiler, MD FRCPC
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 20, 2020
First Posted
March 24, 2020
Study Start
July 23, 2020
Primary Completion
August 2, 2023
Study Completion
August 2, 2023
Last Updated
January 19, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share